{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:03:47Z","timestamp":1784394227914,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Suqian Social Development Science and Technology Support Fund Project, Jiangsu Province","award":["KY202315"],"award-info":[{"award-number":["KY202315"]}]},{"name":"Suzhou Gusu talent plan for Health Technical Personnel project","award":["GSWS2021024"],"award-info":[{"award-number":["GSWS2021024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00335-026-10260-1","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T16:27:19Z","timestamp":1784392039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia-induced mechanism of TNBC promoting tumour cell proliferation through exosomal miRNA"],"prefix":"10.1007","volume":"37","author":[{"given":"Xiangxin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"10260_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28041802","author":"M Banerjee","year":"2023","unstructured":"Banerjee M, Rajeswari VD (2023) Critical review on the different roles of exosomes in TNBC and exosomal-mediated delivery of microRNA\/siRNA\/lncRNA and drug targeting signalling pathways in triple-negative breast cancer. Molecules. https:\/\/doi.org\/10.3390\/molecules28041802","journal-title":"Molecules"},{"key":"10260_CR2","doi-asserted-by":"publisher","DOI":"10.5603\/RPOR.a2022.0025","author":"J Bessa","year":"2022","unstructured":"Bessa J, Marta GN (2022) Triple-negative breast cancer and radiation therapy. Rep Pract Oncol Radiother. https:\/\/doi.org\/10.5603\/RPOR.a2022.0025","journal-title":"Rep Pract Oncol Radiother"},{"issue":"1","key":"10260_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/s12967-024-05529-5","volume":"22","author":"G Biao","year":"2024","unstructured":"Biao G, Yafei W, Xianzhou Z, Hao J, Feng H, Chonghui L et al (2024) Identification and validation of inflammatory subtypes in intrahepatic cholangiocellular carcinoma. J Transl Med 22(1):730","journal-title":"J Transl Med"},{"key":"10260_CR4","doi-asserted-by":"publisher","first-page":"117211","DOI":"10.1016\/j.biopha.2024.117211","volume":"178","author":"L Bing","year":"2024","unstructured":"Bing L, Ye Y, Qianheng J, Tao M, Xiaodan L, Yan L (2024) How neutrophils shape the immune response of triple-negative breast cancer: Novel therapeutic strategies targeting neutrophil extracellular traps. Biomed Pharmacother 178:117211","journal-title":"Biomed Pharmacother"},{"key":"10260_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051253","author":"M Bou Zerdan","year":"2021","unstructured":"Bou Zerdan M, Ghorayeb T, Saliba F, Allam S, Bou Zerdan M, Yaghi M et al (2021) Triple negative breast cancer: updates on classification and treatment in 2021. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14051253","journal-title":"Cancers (Basel)"},{"key":"10260_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T (2016) The Gene Expression Omnibus Database. Methods Mol Biol 1418:93\u2013110","journal-title":"Methods Mol Biol"},{"key":"10260_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1340634","volume":"14","author":"W Du","year":"2024","unstructured":"Du W, Xia X, Hu F, Yu J (2024) Extracellular matrix remodeling in the tumor immunity. Front Immunol 14:1340634","journal-title":"Front Immunol"},{"issue":"3","key":"10260_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3390\/cancers18030361","volume":"18","author":"K Dynarowicz","year":"2026","unstructured":"Dynarowicz K, Bartusik-Aebisher D, Czech S, Kawczyk-Krupka A, Aebisher D (2026) A Decade of Innovation in Breast Cancer (2015\u20132025): A Comprehensive Review of Clinical Trials, Targeted Therapies and Molecular Perspectives. Cancers 18(3):361","journal-title":"Cancers"},{"issue":"4","key":"10260_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/path.5902","volume":"257","author":"E Gadaleta","year":"2022","unstructured":"Gadaleta E, Thorn GJ, Ross-Adams H, Jones LJ, Chelala C (2022) Field cancerization in breast cancer. J Pathol 257(4):561\u2013574","journal-title":"J Pathol"},{"key":"10260_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01440-5","author":"G He","year":"2022","unstructured":"He G, Peng X, Wei S, Yang S, Li X, Huang M et al (2022) Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-021-01440-5","journal-title":"Mol Cancer"},{"key":"10260_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01335-3","author":"Z Jing-Nan","year":"2024","unstructured":"Jing-Nan Z, Ze Z, Zhen-Lin H, Qian G, Ze-Qi W, Chuang K et al (2024) Isotoosendanin inhibits triple-negative breast cancer metastasis by reducing mitochondrial fission and lamellipodia formation regulated by the Smad2\/3-GOT2-MYH9 signaling axis. Acta Pharmacol Sin. https:\/\/doi.org\/10.1038\/s41401-024-01335-3","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10260_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12272-022-01387-1","volume":"45","author":"SB Kim","year":"2022","unstructured":"Kim SB (2022) Function and therapeutic development of exosomes for cancer therapy. Arch Pharm Res 45(5):295\u2013308","journal-title":"Arch Pharm Res"},{"issue":"5","key":"10260_CR13","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3390\/ijms27052109","volume":"27","author":"N Kimta","year":"2026","unstructured":"Kimta N, Majdalawieh MA, Majdalawieh AF (2026) The Future of Breast Cancer Treatment: From Conventional Wisdom to Nanotechnology-Enabled Precision. Int J Mol Sci 27(5):2109","journal-title":"Int J Mol Sci"},{"key":"10260_CR14","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.2147\/IJN.S272378","volume":"15","author":"VC Kok","year":"2020","unstructured":"Kok VC, Yu C-C (2020) Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development. Int J Nanomed 15:8019\u20138036","journal-title":"Int J Nanomed"},{"key":"10260_CR15","doi-asserted-by":"publisher","DOI":"10.2174\/0113816128406867251204172244","author":"A Kuttiappan","year":"2026","unstructured":"Kuttiappan A, Chenchula S, Karunakaran PR, Talagampala SV, Amerneni LS, Amerneni KC et al (2026) Breast cancer drug resistance: precision targeting of ER and HER2 signalling networks. Curr Pharm Des. https:\/\/doi.org\/10.2174\/0113816128406867251204172244","journal-title":"Curr Pharm Des"},{"key":"10260_CR16","first-page":"15","volume":"14","author":"M Maqbool","year":"2022","unstructured":"Maqbool M, Bekele F, Fekadu G (2022) Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review. Breast Cancer: Targets Therapy 14:15\u201324","journal-title":"Breast Cancer: Targets Therapy"},{"key":"10260_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/membranes12080775","author":"L Meng","year":"2022","unstructured":"Meng L, Song K, Li S, Kang Y (2022) Exosomes: small vesicles with important roles in the development, metastasis and treatment of breast cancer. Membranes. https:\/\/doi.org\/10.3390\/membranes12080775","journal-title":"Membranes"},{"key":"10260_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/1533033818821421","author":"Y Meng","year":"2019","unstructured":"Meng Y, Sun J, Wang X, Hu T, Ma Y, Kong C et al (2019) Exosomes: a promising avenue for the diagnosis of breast cancer. Technol Cancer Res Treat. https:\/\/doi.org\/10.1177\/1533033818821421","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"10260_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s11033-026-11635-y","volume":"53","author":"MZ Moghadam","year":"2026","unstructured":"Moghadam MZ, Shafieesabet M, Jamshidi N, Jamshidi N (2026) The role of targeted exosomes in improving drug delivery in breast cancer: challenges and prospects. Mol Biol Rep 53(1):791","journal-title":"Mol Biol Rep"},{"key":"10260_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1537313","volume":"16","author":"Y Mu","year":"2025","unstructured":"Mu Y, Yang M, Liu J, Yao Y, Sun H, Zhuang J (2025) Exosomes in hypoxia: generation, secretion, and physiological roles in cancer progression. Front Immunol 16:1537313","journal-title":"Front Immunol"},{"key":"10260_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69183-z","author":"S Naipeng","year":"2024","unstructured":"Naipeng S, Saisai C, Dong W, Tiange W, Nieke Z, Ming C et al (2024) MDK promotes M2 macrophage polarization to remodel the tumour microenvironment in clear cell renal cell carcinoma. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-024-69183-z","journal-title":"Sci Rep"},{"key":"10260_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071796","author":"O Obidiro","year":"2023","unstructured":"Obidiro O, Battogtokh G, Akala EO (2023) Triple negative breast cancer treatment options and limitations: future outlook. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15071796","journal-title":"Pharmaceutics"},{"key":"10260_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000357","author":"JH Park","year":"2018","unstructured":"Park JH, Ahn J-H, Kim S-B (2018) How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies. ESMO Open. https:\/\/doi.org\/10.1136\/esmoopen-2018-000357","journal-title":"ESMO Open"},{"issue":"3","key":"10260_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-026-02281-7","volume":"31","author":"A Sengupta","year":"2026","unstructured":"Sengupta A, Saha P, Chakraborty R, Maiti AK, Chakraborty S, Datta A et al (2026) Breast cancer: taxonomy, distribution analysis, risk factors, predictive biomarkers, and modern treatment method. Apoptosis 31(3):77","journal-title":"Apoptosis"},{"key":"10260_CR25","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13238","author":"Y Shi","year":"2022","unstructured":"Shi Y, Qiu B, Huang L, Lin J, Li Y, Ze Y et al (2022) Exosomes and ferroptosis: roles in tumour regulation and new cancer therapies. PeerJ. https:\/\/doi.org\/10.7717\/peerj.13238","journal-title":"PeerJ"},{"issue":"3","key":"10260_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/1061186X.2025.2550589","volume":"34","author":"S Sofi","year":"2026","unstructured":"Sofi S, Jan N, Masoodi G, Mir AA, Mir MA (2026) Combating chemoresistance in breast cancer: exploring tumour microenvironment, combination therapies and drug repurposing strategies. J Drug Target 34(3):336\u2013357","journal-title":"J Drug Target"},{"key":"10260_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1561464","volume":"12","author":"PK Tiwari","year":"2025","unstructured":"Tiwari PK, Chaudhary AA, Gupta S, Chouhan M, Singh HN, Rustagi S et al (2025) Extracellular vesicles in triple-negative breast cancer: current updates, challenges and future prospects. Front Mol Biosci 12:1561464","journal-title":"Front Mol Biosci"},{"key":"10260_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040916","author":"E Vagia","year":"2020","unstructured":"Vagia E, Mahalingam D, Cristofanilli M (2020) The landscape of targeted therapies in TNBC. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12040916","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10260_CR29","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.cell.2012.11.024","volume":"151","author":"L Valbona","year":"2012","unstructured":"Valbona L, Liang Z, Alicia MV-P, Abiodun AO, Mohammad RI, Elaine C et al (2012) Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151(7):1542\u20131556","journal-title":"Cell"},{"key":"10260_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01651-2","author":"K VanderVorst","year":"2023","unstructured":"VanderVorst K, Dreyer CA, Hatakeyama J, Bell GRR, Learn JA, Berg AL et al (2023) Vangl-dependent Wnt\/planar cell polarity signaling mediates collective breast carcinoma motility and distant metastasis. Breast Cancer Res. https:\/\/doi.org\/10.1186\/s13058-023-01651-2","journal-title":"Breast Cancer Res"},{"key":"10260_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/10732748261448980","volume":"33","author":"J Wang","year":"2026","unstructured":"Wang J, Ye J (2026) The role and mechanisms of tumor-derived exosomes in the formation of the premetastatic niche. Cancer Control 33:10732748261448980","journal-title":"Cancer Control"},{"key":"10260_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1022725","author":"JW Weaver","year":"2022","unstructured":"Weaver JW, Zhang J, Rojas J, Musich PR, Yao Z, Jiang Y (2022) The application of exosomes in the treatment of triple-negative breast cancer. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2022.1022725","journal-title":"Front Mol Biosci"},{"key":"10260_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02594-y","author":"W-X Xu","year":"2022","unstructured":"Xu W-X, Wang D-D, Zhao Z-Q, Zhang H-D, Yang S-J, Zhang Q et al (2022) Exosomal microRNAs shuttling between tumor cells and macrophages: cellular interactions and novel therapeutic strategies. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-022-02594-y","journal-title":"Cancer Cell Int"},{"key":"10260_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00468-0","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA (2022) Triple negative breast cancer: pitfalls and progress. NPJ Breast Cancer. https:\/\/doi.org\/10.1038\/s41523-022-00468-0","journal-title":"NPJ Breast Cancer"},{"issue":"9","key":"10260_CR35","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/2159-8290.CD-19-1352","volume":"10","author":"D Zhao","year":"2020","unstructured":"Zhao D, Cai L, Lu X, Liang X, Li J, Chen P et al (2020) Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer. Cancer Discov 10(9):1374\u20131387","journal-title":"Cancer Discov"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-026-10260-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T16:27:21Z","timestamp":1784392041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-026-10260-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10260"],"URL":"https:\/\/doi.org\/10.1007\/s00335-026-10260-1","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the studies involving animals were in accordance with the ethical standards of the Institutional Animal Care and Use Committee (IACUC) of The Second Affiliated Hospital of Soochow University.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"90"}}